Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib

被引：0
|
作者：
Wada, Y. [1 ]
Takami, Y. [1 ]
Matsushima, H. [1 ]
Ryu, T. [1 ]
Mikagi, K. [1 ]
Saitsu, H. [1 ]
机构：
[1] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Hepatobiliary Pancreat Surg, Fukuoka, Japan
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)31709-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-103
引用
收藏
页码：S630 / S631
页数：2
相关论文
共 50 条
  • [31] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Inghilesi, Andrea L.
    Gallori, Donatella
    Antonuzzo, Lorenzo
    Forte, Paolo
    Tomcikova, Daniela
    Arena, Umberto
    Colagrande, Stefano
    Pradella, Silvia
    Fani, Bernardo
    Gianni, Elena
    Boni, Luca
    Laffi, Giacomo
    Di Costanzo, Francesco
    Marra, Fabio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (03) : 786 - 794
  • [32] Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
    Stras, Wojciech
    Gotlib, Joanna
    Malkowski, Piotr
    Wasiak, Dariusz
    Sliwczynski, Andrzej
    Panczyk, Mariusz
    Tronina, Olga
    Brzozowska, Melania
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [33] Survival outcomes of metastatic/unresectable hepatocellular carcinoma patients treated with sorafenib
    Chantharusamee, Jomjit
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Targeted genome profiling in patients with advanced hepatocellular carcinoma treated with sorafenib
    Kang, Wonseok
    Kim, Kyung
    Lee, Joon Hyeok
    Lim, Ho Yeong
    Park, Woong-Yang
    Lee, Jeeyun
    Paik, Yong Han
    CANCER RESEARCH, 2017, 77
  • [35] The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib
    Sarpel, Umut
    Spivack, John H.
    Berger, Yaniv
    Heskel, Marina
    Aycart, Samantha N.
    Sweeney, Robert
    Edwards, Martin P.
    Labow, Daniel M.
    Kim, Edward
    HPB, 2016, 18 (05) : 411 - 418
  • [36] Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
    Soria, Anna
    Calvo, Mariona
    Casas, Meritxell
    Vidales, Zara
    Munoz-Martinez, Sergio
    Sapena, Victor
    Puigvehi, Marc
    Canillas, Lidia
    Guardeno, Raquel
    Gallego, Adolfo
    Minguez, Beatriz
    Horta, Diana
    Clos, Ariadna
    Montoliu, Silvia
    Roget, Merce
    Reig, Maria
    Vergara, Mercedes
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
    Kim, Hwi Young
    Park, Joong-Won
    Nam, Byung-Ho
    Kim, Hyun Keun
    Choi, Joon-Il
    Kim, Tae Hyun
    Kim, Hyun Beom
    Kim, Chang-Min
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (11) : 1612 - 1618
  • [38] The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Woerns, Marcus A.
    Koch, Sandra
    Niederle, Ina M.
    Marquardt, Jens U.
    Nguyen-Tat, Marc
    Gamstaetter, Thomas
    Schuchmann, Marcus
    Schulze-Bergkamen, Henning
    Galle, Peter R.
    Weinmann, Arndt
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (05) : 408 - 413
  • [39] Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib
    Chen, D.
    Zhao, P.
    Li, S. -Q.
    Xiao, W. -K.
    Yin, X. -Y.
    Peng, B. -G.
    Liang, L. -J.
    EJSO, 2013, 39 (09): : 974 - 980
  • [40] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Andrea L Inghilesi
    Donatella Gallori
    Lorenzo Antonuzzo
    Paolo Forte
    Daniela Tomcikova
    Umberto Arena
    Stefano Colagrande
    Silvia Pradella
    Bernardo Fani
    Elena Gianni
    Luca Boni
    Giacomo Laffi
    Francesco Di Costanzo
    Fabio Marra
    World Journal of Gastroenterology, 2014, 20 (03) : 786 - 794
12345